Corlanor and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Corlanor (ivabradine hydrochloride), especially for people who are male, 20-29 old, also take Aspirin, and have Migraine.

The phase IV clinical study analyzes which people have Stroke when taking Corlanor. It is created by eHealthMe based on reports of 2,372 people who have side effects when taking Corlanor from the FDA, and is updated regularly.

What is Corlanor?

Corlanor has active ingredients of ivabradine hydrochloride. eHealthMe is studying from 2,453 Corlanor users. Check the latest studies of Corlanor.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,325 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.



On Jun, 25, 2026

2,372 people reported to have side effects when taking Corlanor.
Among them, 13 people (0.55%) have Stroke.

Could Corlanor cause Stroke?

Among these 13 people:

What is the gender of people who have Stroke when taking Corlanor? *

  • female: 50 %
  • male: 50 %

What is the age of people who have Stroke when taking Corlanor? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 44.44 %
  • 30-39: 11.11 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 11.11 %

What are other drugs people take besides Corlanor? *

  1. Aimovig: 4 people, 30.77%
  2. Vitamin D3: 4 people, 30.77%
  3. Fioricet: 4 people, 30.77%
  4. Aspirin: 4 people, 30.77%
  5. Bicillin: 3 people, 23.08%
  6. Cardizem: 3 people, 23.08%
  7. Clindamycin Phosphate: 3 people, 23.08%
  8. Diazepam: 3 people, 23.08%
  9. Epzicom: 3 people, 23.08%
  10. Pepcid: 3 people, 23.08%

What are other side effects people have besides Stroke? *

  1. Agraphia (a loss of the ability to write or to express thoughts in writing because of a brain lesion): 4 people, 30.77%
  2. Migraine (headache): 4 people, 30.77%
  3. Vision Blurred: 3 people, 23.08%
  4. Bleeding Disorders: 3 people, 23.08%
  5. Central Nervous System Lesion (an abnormality in tissue of brain or spinal cord): 3 people, 23.08%
  6. Cerebellar Infarction (impaired blood circulation to cerebellum): 3 people, 23.08%
  7. Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 23.08%
  8. Dyspnea (difficult or laboured breathing): 3 people, 23.08%
  9. Fever: 3 people, 23.08%
  10. Folate Deficiency (lack of folic acid): 3 people, 23.08%

What are the existing conditions these people have? *

  1. Postural Orthostatic Tachycardia Syndrome (abnormal increase in heart rate on becoming upright): 4 people, 30.77%
  2. Migraine (headache): 4 people, 30.77%
  3. Cardiac Failure: 2 people, 15.38%
  4. High Blood Pressure: 1 person, 7.69%
  5. Heart Attack: 1 person, 7.69%
  6. Arrhythmias (irregular heartbeat): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Corlanor and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Corlanor:

Stroke treatments and more:

How severe was Stroke and when was it recovered:

Expand to all the drugs that have ingredients of ivabradine hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Corlanor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Browse all the conditions that are associated with Stroke:


How the study uses the data?

The study uses data from the FDA. It is based on ivabradine hydrochloride (the active ingredients of Corlanor) and Corlanor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: